Pfizer Stock Undervalued, Fluctuates

This is a Trouble news story, published by Yahoo Finance, that relates primarily to NYSE news.

Trouble news

For more Trouble news, you can click here:

more Trouble news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

healthcare stock

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest COVID vaccine sales news, vaccine demand news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

Pfizer Stock

The Motley Fool

•

Is Pfizer Stock in Trouble?

Summary

Nutrition label

76% Informative

Pfizer ( NYSE : PFE ) posted some decent earnings numbers, but investors can't shake the fear that the business is facing daunting headwinds that could send its $145 billion valuation lower in the months and years ahead .

Pfizer 's stock is trading at a heavily discounted forward price-to-earnings multiple (based on analyst estimates) of less than 9 , which suggests that investors are feeling a bit concerned about the company's future.

Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month . The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002

Stock Advisor returns as of November 25, 2024 Is Pfizer Stock in Trouble ? was originally published by The Motley Fool .

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive

Hate speech